MnetTV

Search Manufacturing.net
Today in Manufacturing.Net

Resources
Bookstore
Career Center
Events Calendar
Links
White Papers

Free White Papers

News
Featured Articles
Financial News
Global Manufacturing
Government News
Mergers & Acquisitions
News Archive
People in the News

Amazon

Market Sectors
Aerospace
Automotive/Transportation
Chemical/Petroleum
Food/Beverage
Medical
Metals
Pharmaceuticals/Biotech
Plastics/Rubber
Other Manufacturing

Industry Focus
Design & Development
Electrical & Electronics
Energy
Environmental
Facilities & Operations
Labor Relations
Manufacturing Technology
Materials
Quality
Safety
Supply Chain

Career Center
CareerBuilder.com


About Us
Editorial Contacts
Advertise with Us

Our Partner Sites
Chem.Info
ECN
Food Manufacturing
IMPO (Industrial Maintenance & Plant Operation)
Medical Design Technology
Pharmaceutical Processing
Product Design & Development
R & D Magazine
Wireless Design & Development
Wireless Week





Advertise with Mnet



Drug And Medical Device Laws Go On Trial

Manufacturing.Net - May 14, 2008

Printer Friendly     E-mail to a Colleague


WASHINGTON (AP) -- Doctors, lawyers and a movie star are expected to criticize government regulations Wednesday that have shielded drug and medical device companies from lawsuits brought by patients.

For decades consumers who felt they had been injured by a drug or device have used state laws to sue companies for damages. But in 2006 the Food and Drug Administration said any product that meets its standards for approval is not subject to state liability laws.

The Supreme Court and others are still grappling with the issue, but consumer advocates fear rulings that favor federal rules could make it more difficult for patients to sue drugmakers -- potentially saving those companies billions of dollars.

More than a half dozen witnesses are expected to testify on the issue at a 10 a.m. hearing before the House Committee on Oversight, chaired by Rep. Henry Waxman, D-Calif.

Film actor Dennis Quaid is expected to join the usual lineup of medical, regulatory and legal experts. Quaid and his wife, Kimberly, are suing Deerfield, Ill.-based Baxter Healthcare Corp. for putting vastly different doses of a blood-thinner into confusingly similar packages.

The Quaids allege that their infant twins were given 2,000 times more blood thinner than prescribed because of Baxter's packaging. The massive overdose caused the twins' blood to thin to dangerous levels, though both made a full recovery.

Lawmakers will hear from former FDA Commissioner David Kessler and New England Journal of Medicine Editor Gregory Curfman. No company representatives are scheduled to testify.

Earlier this year the Supreme Court left in place a ruling favoring patient lawsuits in a case against Pfizer subsidiary Warner Lambert. Patients who used its diabetes drug Rezulin had sued the company for allegedly misleading FDA about its risks. The court was split over whether FDA regulations should overrule state liability laws, upholding a lower court decision that favored the patients.

But in February justices ruled in a case against Medtronic Inc. that federal rules pre-empt lawsuits in state courts against medical device manufacturers.

Waxman and Rep. Frank Pallone, D-N.J., have drafted legislation that would effectively nullify that decision, allowing consumers to seek damages from device makers. A spokesman for Pallone said the bill will be introduced in the coming weeks.


Printer Friendly     E-mail to a Colleague



Talkback!
Manufacturing.net is pleased to provide you an opportunity to share your opinions on any of the news stories or articles on our site. We reserve the right to edit/remove comments.
Viewing 0 User Comments
Add a Comment


Add a Comment...

E-Mail:
The content of this field is kept private and will not be shown publicly.

Subject:
Comment:

 

     



  

THIS WEEK'S MOST
READ NEWS ITEMS




Aerospace

Lockheed Martin Eliminating Up To 100 Jobs

GE Aviation Buys Walter Engines

Delays Possible After Boeing 787 Section Damaged


Automotive/Transportation

Analysts: Future Bleak For Detroit Automakers

Rookie Bids For $3B Toronto Light-Rail Contract

Canadian Auto Parts Maker Closes 11 Plants

Pharmaceuticals/Biotech

Bayer Investing $156 Million In Brazil

Pfizer Settles Pollution Violations

Merck’s North Carolina Plant To Get $300M Expansion
News Video